Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA
1997

Enhancing Drug Sensitivity in Cancer Cells

publication Evidence: high

Author Information

Author(s): Y Kato, S Matsukawa, R Muraoka, N Tanigawa

Primary Institution: Fukui Medical School

Hypothesis

Can transfection of tumor cells with PD-ECGF cDNA increase their sensitivity to pyrimidine antimetabolites?

Conclusion

Transfection of PD-ECGF genes significantly enhances the sensitivity of cancer cells to certain anti-cancer drugs and induces a bystander effect.

Supporting Evidence

  • PC9-DPE2 cells had over 50 times higher dThdPase activity than control cells.
  • Transfected cells showed significantly increased sensitivity to 5'-DFUR, tegafur, and 5-FU.
  • The bystander effect was observed without direct cell contact.

Takeaway

Scientists found a way to make cancer cells more sensitive to drugs by changing their genes, which could help treat cancer better.

Methodology

The study involved transfecting PC-9 lung cancer cells with PD-ECGF cDNA and measuring their sensitivity to various drugs.

Limitations

The study primarily focused on in vitro conditions, which may not fully represent in vivo scenarios.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication